Alexandros Simistiras

Alexandros Simistiras

Auto-generated profile, based on publicly available information

Alexandros Simistiras

Institute for Bioinnovation, Biomedical Sciences Research Center ‘Alexander Fleming’, Vari, Greece

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
SFStefano Figliozzi
Stefano Figliozzi
EKEleni Kollia
Eleni Kollia
ASAlexandros Simistiras
Alexandros Simistiras
ACAntonia Camporeale
Antonia Camporeale
KSKamil Stankowski
Kamil Stankowski
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
Purpose To perform a systematic review and meta-analysis to assess the effect of enzyme replacement therapy on cardiac MRI parameters in patients with Fabry disease. Materials and Methods A systematic literature search was conducted from January 1, 2000, through January 1, 2024, in PubMed, ClinicalTrials.gov, Embase, and Cochrane Library databases. Study outcomes were changes in the following parameters: (a) left ventricular wall mass (LVM), measured in grams; (b) LVM indexed to body mass index, measured in grams per meters squared; (c) maximum left ventricular wall thickness (MLVWT), measured in millimeters; (d) late gadolinium enhancement (LGE) extent, measured in percentage of LVM; and (e) native T1 mapping, measured in milliseconds. A random-effects meta-analysis of the pooled mean differences between baseline and follow-up parameters was conducted. The study protocol was registered in PROSPERO (CRD42022336223). Results The final analysis included 11 studies of a total of 445 patients with Fabry disease (mean age ± SD, 41 years ± 11; 277 male, 168 female). Between baseline and follow-up cardiac MRI, the following did not change: T1 mapping (mean difference, 6 msec [95% CI: -2, 15]; two studies, 70 patients, I2 = 88%) and LVM indexed (mean difference, -1 g/m2 [95% CI: -6, 3]; four studies, 290 patients, I2 = 81%). The following measures minimally decreased: LVM (mean difference, -18 g [95% CI: -33, -3]; seven studies, 107 patients, I2 = 96%) and MLVWT (mean difference, -1 mm [95% CI: -2, -0.02]; six studies, 151 patients, I2 = 90%). LGE extent increased (mean difference, 1% [95% CI: 1, 1]; three studies, 114 patients, I2 = 85%). Conclusion In patients with Fabry disease, enzyme replacement therapy was associated with stabilization of LVM, MLVWT, and T1 mapping values, whereas LGE extent mildly increased. Keywords: Fabry Disease, Enzyme Replacement Therapy (ERT), Cardiac MRI, Late Gadolinium Enhancement (LGE) Supplemental material is available for this article. © RSNA, 2024.

3 December 2025 in Communications Medicine
Verified
Journal Article
Open access
PDF file
ELEleni M. Loizidou
Eleni M. Loizidou
APAikaterini Palaiokrassa
Aikaterini Palaiokrassa
SASamuel Opoku Asiedu
Samuel Opoku Asiedu
ASAlexandros Simistiras
Alexandros Simistiras
PBPetros Barmpounakis
Petros Barmpounakis
ADAntigone S Dimas
Antigone S Dimas
Background: Dietary interventions are powerful tools for disease prevention and health promotion, yet the molecular mechanisms by which diet influences health remain incompletely understood. Investigating the effects of diet in healthy individuals enables characterization of molecular and physiological responses in the absence of disease-related confounders and facilitates the identification of diet-responsive pathways underlying physiological regulation. Methods: We investigated the metabolic and immune effects of short-term dietary restriction of animal products in a unique group of apparently healthy individuals (N = 200) who alternate between omnivory and animal product restriction for religious reasons. We profiled clinical biomarkers and immune parameters during both dietary states, alongside a control group of continuously omnivorous individuals (N = 211). Results: Short-term restriction is associated with reductions in total and non-high-density lipoprotein cholesterol, urea, creatinine, alanine aminotransferase, and gamma-glutamyltransferase, and a concurrent 73% reduction of normal-range C-reactive protein levels. Immune profiling reveals reductions in frequencies of non-classical monocytes, CD56⁺ natural killer cells, and CD8⁺ memory T cells, accompanied by an increased response of cytokine IL-10, suggesting enhanced immune regulation against inflammation. Although most changes are in a direction suggesting beneficial health effects, levels of alkaline phosphatase increase upon restriction, implying possible negative effects on bone turnover or liver function. Conclusions: Short-term animal product restriction mostly improves systemic metabolic and immune health markers and may lower chronic inflammatory disease risk. Our findings highlight the value of studying diet in the absence of disease to reveal adaptive molecular changes and emphasize the translational potential of short-term dietary interventions in altering health-related risks.

24 February 2026 in Advanced Science
Verified
Journal Article
Open access
PDF file
CEChristina Emmanouil
Christina Emmanouil
MAMaria Anezaki
Maria Anezaki
ASAlexandros Simistiras
Alexandros Simistiras
SGStavros Glentis
Stavros Glentis
NSNikolaos Scarmeas
Nikolaos Scarmeas
ADAntigone S Dimas
Antigone S Dimas
Diet strongly influences the gut microbiome, which in turn influences health, yet the effects of dietary patterns on microbiome composition and function in humans remain underexplored. A unique group of apparently healthy individuals from Greece, who alternate between omnivory and restriction of animal products for religious reasons (periodically restricted group, n = 200), has been profiled. Using 16S rRNA sequencing, plasma metabolomics, and proteomics, the impact of three‐to‐four weeks of dietary restriction on gut microbiome composition and function is assessed and associations with host plasma biology are explored. Findings are compared to a continuously omnivorous group profiled in parallel (non‐restricted group, n = 211). Animal product restriction reduced microbial diversity, primarily affecting rare taxa, and altered the abundance of nearly one‐third of bacterial genera. Inferred functional shifts included downregulation of pathways contributing to cholesterol biosynthesis and purine degradation, alongside upregulation of vitamin B2 and tryptophan biosynthesis, suggesting compensatory microbial responses to dietary nutrient depletion. Multi‐omics integration revealed four microbial‐metabolite‐protein clusters, including a diet‐responsive module associating Negativibacillus with metabolic regulator FGF21 and intermediate‐density lipoproteins. These findings demonstrate rapid adaptive plasticity of the human gut microbiome in response to short‐term dietary restriction and highlight candidate microbial and molecular pathways associated with animal product restriction and host biology.

25 July 2025 in bioRxiv
Verified
Preprint
Open access
ASAlexandros Simistiras
Alexandros Simistiras
OBOzvan Bocher
Ozvan Bocher
CEChristina Emmanouil
Christina Emmanouil
ASAnargyros Skoulakis
Anargyros Skoulakis
SGStavros Glentis
Stavros Glentis
ADAntigone S Dimas
Antigone S Dimas
The effect of diet on genetic regulation in humans remains largely unexplored. Here, we investigated gene-by-diet interactions in a unique group of apparently healthy individuals (N=200) who alternate between omnivory and dietary restriction of animal products for religious reasons. Using longitudinal plasma proteomic and genotypic data, we identified diet-responsive cis-protein quantitative trait loci (cis-pQTLs) including gain of genetic regulatory effects for LBR and MSRA, proteins linked to cholesterol and methionine metabolism respectively. LBR-associated diet-responsive cis-pQTL rs74148404 showed suggestive evidence of colocalization with obesity exclusively under dietary restriction, suggesting diet-dependent differential genetic risk for disease. Additionally, a novel dietary restriction-associated cis-pQTL for metabolic regulator FGF21 colocalized with eosinophil and platelet traits pointing to diet-sensitive immunometabolic signalling. By parallel profiling of a continuously omnivorous control group (N=211), we also uncovered seasonally dynamic gain and loss of genetic regulation for proteins linked to apoptosis in immune system pathways (MAVS, CASP3, PDLIM7 IL12RB1), effects likely masked by animal product restriction. These findings reveal dynamic diet- and season-sensitive regulatory mechanisms with implications for precision nutrition and individualized disease prevention strategies, and underscore the need to integrate environmental context into genetic studies of health and disease.

27 August 2025 in Research Square
Verified
Preprint
Open access
PDF file
ADAntigone S Dimas
Antigone S Dimas
ASAlexandros Simistiras
Alexandros Simistiras
OBOzvan Bocher
Ozvan Bocher
CEChristina Emmanouil
Christina Emmanouil
ASAnargyros Skoulakis
Anargyros Skoulakis
KRKonstantinos Rouskas
Konstantinos Rouskas
The effect of diet on genetic regulation in humans remains largely unexplored. Here, we investigated gene-by-diet interactions in a unique group of apparently healthy individuals (N=200) who alternate between omnivory and dietary restriction of animal products for religious reasons. Using longitudinal plasma proteomic and genotypic data, we identified diet-responsive cis-protein quantitative trait loci (cis-pQTLs) including gain of genetic regulatory effects for LBR and MSRA, proteins linked to cholesterol and methionine metabolism respectively. LBR-associated diet-responsive cis-pQTL rs74148404 showed suggestive evidence of colocalization with obesity exclusively under dietary restriction, suggesting diet-dependent differential genetic risk for disease. Additionally, a novel dietary restriction-associated cis-pQTL for metabolic regulator FGF21 colocalized with eosinophil and platelet traits pointing to diet-sensitive immunometabolic signalling. By parallel profiling of a continuously omnivorous control group (N=211), we also uncovered seasonally dynamic gain and loss of genetic regulation for proteins linked to apoptosis in immune system pathways (MAVS, CASP3, PDLIM7 IL12RB1), effects likely masked by animal product restriction. These findings reveal dynamic diet- and season-sensitive regulatory mechanisms with implications for precision nutrition and individualized disease prevention strategies, and underscore the need to integrate environmental context into genetic studies of health and disease.

8 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAlexandros Simistiras
Alexandros Simistiras
OBOzvan Bocher
Ozvan Bocher
CEChristina Emmanouil
Christina Emmanouil
ASAnargyros Skoulakis
Anargyros Skoulakis
SGStavros Glentis
Stavros Glentis
ADAntigone S Dimas
Antigone S Dimas
The effect of diet on genetic regulation in humans remains largely unexplored. Here, we investigate gene-diet interactions in a unique group of healthy individuals (N = 200) who alternate between omnivory and dietary restriction of animal products for religious reasons. Using longitudinal proteomic and genotype data, we identify diet-responsive cis-pQTLs and highlight regulatory effects on LBR and MSRA, proteins involved in cholesterol and methionine metabolism respectively. LBR-associated cis-pQTL rs74148404 colocalizes with obesity exclusively under dietary restriction, suggesting diet-dependent modulation of genetic risk. We also show that a diet-dependent cis-pQTL for metabolic regulator FGF21 colocalizes with eosinophil and platelet traits pointing to diet-sensitive immunometabolic signalling. By parallel profiling of a continuously omnivorous control group (N = 211), we uncover seasonally dynamic genetic regulation for proteins linked to apoptosis in immune system pathways (MAVS, CASP3, PDLIM7, IL12RB1), effects likely masked by animal product restriction. These findings reveal dynamic diet- and season-sensitive regulatory mechanisms with implications for precision nutrition and individualized disease prevention strategies, and underscore the need to integrate environmental context into genetic studies of health and disease.